|
Volumn 8, Issue 11, 2007, Pages 16-21
|
Classifying and managing allergic conjunctivitis
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTAZOLINE;
ANTIHISTAMINIC AGENT;
ANTISTINE PRIVINE EYE DROPS;
CORTICOSTEROID;
CROMOGLYCATE DISODIUM;
CROMOLUX EYE DROPS;
CYCLOSPORIN A;
EYE DROPS;
FLAREX;
FLUOROMETHOLONE;
HAMAMELIS EXTRACT;
IMMUNOMODULATING AGENT;
KETOROLAC TROMETAMOL;
KETOTIFEN FUMARATE;
LEVOCABASTINE;
LIVOSTIN EYE DROPS;
MINIMS PREDNISOLONE;
MURINE CLEAR EYES;
NAPHAZOLINE;
NAPHCON FORTE;
NONSTEROID ANTIINFLAMMATORY AGENT;
OLOPATADINE;
OPTREX;
OPTREX EYE DROPS;
PHENIRAMINE;
TETRYZOLINE;
UNCLASSIFIED DRUG;
VISINE ALLERGY WITH ANTIHISTAMINE;
ALLERGIC CONJUNCTIVITIS;
ATOPIC KERATOCONJUNCTIVITIS;
AUSTRALIA;
CATARACT;
CHILDHOOD DISEASE;
CORNEA STROMA;
CORTICOSTEROID THERAPY;
DIFFERENTIAL DIAGNOSIS;
DISEASE CLASSIFICATION;
DRUG EFFICACY;
DRUG SAFETY;
EYE ALLERGY;
EYE INFECTION;
GIANT PAPILLARY CONJUNCTIVITIS;
GLAUCOMA;
HUMAN;
MAST CELL DEGRANULATION;
PATIENT REFERRAL;
PERENNIAL ALLERGIC CONJUNCTIVITIS;
QUALITY OF LIFE;
REVIEW;
SEASONAL ALLERGIC CONJUNCTIVITIS;
SIDE EFFECT;
VERNAL CONJUNCTIVITIS;
|
EID: 37149054007
PISSN: 1443430X
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (2)
|
References (8)
|